The role of MALAT1 correlates with HPV in cervical cancer

Oncology Letters

Volumn 7, Issue 6, 2014, Pages 2135-2141

  Jiang, Yan ^a   Li, Yuehui ^a   Fang, Shujuan ^a   Jiang, Binyuan ^a   Qin, Changfei ^a   Xie, Pingli ^a   Zhou, Guohua ^a   Li, Guancheng ^a  

^a Central South University   (China)

Author keywords

Cell proliferation; Cervical cancer; Human papilloma virus; Metastasis associated lung adenocarcinoma transcript 1

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 6; CYCLIN E;

ARTICLE; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FLOW CYTOMETRY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN CELL; LUNG ADENOCARCINOMA; METASTASIS ( SHOULD GIVE AS PROTEIN OR DISEASE TERM.(MALAT1 IN ITEM); PHENOTYPE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE CERVIX CANCER; WOUND HEALING;

EID: 84898868270     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1996     Document Type: Article

References (38)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Jablonowska D, Marszalek A and Bodnar M: Tabacco smoking, HPV infection and changes in cervix. Przegl Lek 69: 740-743, 2012 (In Polish).
3. Scheffner M, Huibregtse JM, Vierstra RD and Howley PM: The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495-505, 1993.
4. Shaikh F, Sanehi P and Rawal R: Molecular screening of compounds to the predicted Protein-Protein Interaction site of Rb1-E7 with p53- E6 in HPV. Bioinformation 8: 607-612, 2012.
5. Goodwin EC and DiMaio D: Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc Natl Acad Sci USA 97: 12513-12518, 2000.
6. Kornienko AE, Guenzl PM, Barlow DP and Pauler FM: Gene regulation by the act of long non-coding RNA transcription. BMC Biol 11: 59, 2013.
7. Spizzo R, Almeida MI, Colombatti A and Calin GA: Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 31: 4577-4587, 2012.
8. Pandey RR, Mondal T, Mohammad F, et al: Kcnq1ot1 antisense noncoding RNA mediates lineage-specific transcriptional silencing through chromatin-level regulation. Mol Cell 32: 232-246, 2008.
9. Wang X, Arai S, Song X, et al: Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 454: 126-130, 2008.
10. Wang KC and Chang HY: Molecular mechanisms of long noncoding RNAs. Mol Cell 43: 904-914, 2011.
11. Tsai MC, Manor O, Wan Y, et al: Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693, 2010.
12. Gupta RA, Shah N, Wang KC, et al: Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076, 2010.
13. Panzitt K, Tschernatsch MM, Guelly C, et al: Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology 132: 330-342, 2007.
14. Huarte M, Guttman M, Feldser D, et al: A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142: 409-419, 2010.
15. Hung T, Wang Y, Lin MF, et al: Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 43: 621-629, 2011.
16. Ji P, Diederichs S, Wang W, et al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22: 8031-8041, 2003.
17. Yang L, Lin C, Liu W, et al: ncRNA-and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 147: 773-788, 2011.
18. Miyagawa R, Tano K, Mizuno R, et al: Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles. RNA 18: 738-751, 2012.
19. Tripathi V, Ellis JD, Shen Z, et al: The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 39: 925-938, 2010.
20. Luo JH, Ren B, Keryanov S, et al: Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 44: 1012-1024, 2006.
21. Lai MC, Yang Z, Zhou L, et al: Long non-coding RNA MALAT-1 over expression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 29: 1810-1816, 2012.
22. Koshimizu TA, Fujiwara Y, Sakai N, Shibata K and Tsuchiya H: Oxytocin stimulates expression of a noncoding RNA tumor marker in a human neuroblastoma cell line. Life Sci 86: 455-460, 2010.
23. Guffanti A, Iacono M, Pelucchi P, et al: A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics 10: 163, 2009.
24. Yamada K, Kano J, Tsunoda H, et al: Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci 97: 106-112, 2006.
25. Xu C, Yang M, Tian J, Wang X and Li Z: MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol 39: 169-175, 2011.
26. Ying L, Chen Q, Wang Y, Zhou Z, Huang Y and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst 8: 2289-2294, 2012.
27. Ponting CP and Belgard TG: Transcribed dark matter: meaning or myth? Hum Mol Genet 19: R162-R168, 2010.
28. Dermitzakis ET, Reymond A and Antonarakis SE: Conserved non-genic sequences -an unexpected feature of mammalian genomes. Nat Rev Genet 6: 151-157, 2005.
29. Nana-Sinkam SP and Croce CM: Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Mol Oncol 5: 483-491, 2011.
30. Wilusz JE, Freier SM and Spector DL: 3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 135: 919-932, 2008.
31. Guo F, Li Y, Liu Y, Wang J, Li Y and Li G: Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai) 42: 224-229, 2010.
32. Ohtani N, Yamakoshi K, Takahashi A and Hara E: The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. J Med Invest 51: 146-153, 2004.
33. Molinolo AA, Marsh C, El Dinali M, et al: mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas. Clin Cancer Res 18: 2558-2568, 2012.
34. Li Y, Wang F, Xu J, et al: Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 224: 484-495, 2011.
35. Kranjec C and Banks L: A systematic analysis of human papillomavirus (HPV) E6 PDZ substrates identifies MAGI-1 as a major target of HPV type 16 (HPV-16) and HPV-18 whose loss accompanies disruption of tight junctions. J Virol 85: 1757-1764, 2011.
36. Gök M, Heideman DA, van Kemenade FJ, et al: HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 340: c1040, 2010.
37. Karnon J, Peters J, Platt J, Chilcott J, McGoogan E and Brewer N: Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess 8: 1-78, 2004.
38. Cuzick J, Clavel C, Petry KU, et al: Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119: 1095-1101, 2006.